皮下植入式导管药盒系统在不能手术切除的腹腔肿瘤治疗中的应用(附48例分析)  

Application of Implantable Port-Catheter system in treating nonresectable abdominal carinoma (Analysis of 48 Cases).

作　　者：覃晓[1] 林进令[1] 黎乐群[1] 梁水庭[1] 陆云飞[1] 廖清华[1] 

机构地区：[1]广西医科大学第一附院外科

出　　处：《广西医学》1997年第5期735-737,共3页Guangxi Medical Journal

摘　　要：我科自１９９３年以来对４８例不能手术切除的腹腔肿瘤病人通过植入导管药盒系统，进行区域化疗及栓塞治疗，其中４１例为ＰＬＣ病人，ＰＬＣ开腹植入组（２５例）半年、１年和２年生存率分别为７９．６％、４５．２％和２５．１％，动脉穿刺植入组（１６例）分别为８７．５％、７４．５％和３９．１％，２例获得Ⅱ期手术切除。结果表明，ＩＰＣＳ可作为一种简便、实用和有效的中晚期肿瘤的治疗手段。Fourty-eight cases with nonresectable abdominal carcinoma were treated by regional chemotherapy and chemoembolization through Implantable Port-Catheter System (IPCS) in our department since 1993.Among them there were 41 cases of primary liver cancer (PLC).The 6 month,1 year and 2 year survival rates of operative implantation group (25 cases) of PLC were 79.6%,45.2%and 25.1% respectively and artery puncture implantation group (16 cases) were 87.5%,74.5% and 39.1% respectively.Two cases received Ⅱ step resection.The results indicate that IPCS is a simple,practive and effective method in the treatment of advanced tumors.

关 键 词：腹腔肿瘤 药物疗法 肝肿瘤 导管药盒系统 置入 

分 类 号：R735.705[医药卫生—肿瘤]